antibody drug
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
antibody drug
Jul 1, 2024, 18:24 |
Insight
Paolo Tarantino: How long should adjuvant T-DM1 be given for stage I HER2+ eBC?
Paolo Tarantino shared on X: "For how long should adjuvant T-DM1 be given for stage…
Jun 22, 2024, 04:45 |
Blog
Susan Galbraith: I am passionate about supporting the next generation of female leaders in STEM
Susan Galbraith, Executive Vice President in Oncology R&D at AstraZeneca, shared on LinkedIn: "It was…
Aug 15, 2023, 09:15 |
Insight
Paolo Tarantino: Delivering chemo via HER2- and Trop2-targeted Antibody-drug conjugates (ADCs) has reshaped the way we treat Metastatic breast cancer (MBC)
Paolo Tarantino, MD, Clinical Research Fellow at Dana-Farber Cancer Institute, stated on Twitter: "Delivering chemo…
Aug 14, 2023, 17:26 |
Insight
Raffaele Colombo: WHO INN proposed list 129 is out.
In a Twitter post by Raffaele Colombo, Principal Scientist at Zymeworks Inc, it says: ''WHO…
Jul 15, 2023, 17:43 |
Drugs
Awesome talk by Dr. Rana McKay on the future perspectives of new drugs and compounds in RCC - Fabio Schutz
Awesome talk by Dr. Rana McKay on the future perspectives of new drugs and compounds…
All:
5
Posts:
1 - 100
ASCO IDEA - Life-changing experience for the early-career oncologists in LMICs
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Facebook
RSS Feed
Twitter
Linkedin
Youtube